Periodontitis as a promoting factor of T2D: current evidence and mechanisms

被引:0
|
作者
Yuan Su
Leilei Ye
Chen Hu
Yanli Zhang
Jia Liu
Longquan Shao
机构
[1] Southern Medical University (The First People’s Hospital of Shunde),Stomatology Center, Shunde Hospital
[2] Southern Medical University,Stomatological Hospital, School of Stomatology
[3] Southern Medical University,Department of Stomatology, Nanfang Hospital
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Periodontitis is an infectious disease caused by an imbalance between the local microbiota and host immune response. Epidemiologically, periodontitis is closely related to the occurrence, development, and poor prognosis of T2D and is recognized as a potential risk factor for T2D. In recent years, increasing attention has been given to the role of the virulence factors produced by disorders of the subgingival microbiota in the pathological mechanism of T2D, including islet β-cell dysfunction and insulin resistance (IR). However, the related mechanisms have not been well summarized. This review highlights periodontitis-derived virulence factors, reviews how these stimuli directly or indirectly regulate islet β-cell dysfunction. The mechanisms by which IR is induced in insulin-targeting tissues (the liver, visceral adipose tissue, and skeletal muscle) are explained, clarifying the influence of periodontitis on the occurrence and development of T2D. In addition, the positive effects of periodontal therapy on T2D are overviewed. Finally, the limitations and prospects of the current research are discussed. In summary, periodontitis is worthy of attention as a promoting factor of T2D. Understanding on the effect of disseminated periodontitis-derived virulence factors on the T2D-related tissues and cells may provide new treatment options for reducing the risk of T2D associated with periodontitis.
引用
收藏
相关论文
共 50 条
  • [31] Evidence that HNF4α is a positional candidate gene for susceptibility to type 2 diabetes (T2D)
    Love-Gregory, L
    Wasson, J
    Ma, JY
    Permutt, MA
    [J]. DIABETES, 2004, 53 : A276 - A276
  • [32] Metformin use in T2D patients with reduced kidney function: reassuring, more evidence needed
    Anil Pareek
    Shruti Dharmadhikari
    Ravi T. Mehta
    Kumar Naidu
    [J]. International Journal of Diabetes in Developing Countries, 2020, 40 : 638 - 638
  • [33] Metformin use in T2D patients with reduced kidney function: reassuring, more evidence needed
    Pareek, Anil
    Dharmadhikari, Shruti
    Mehta, Ravi T.
    Naidu, Kumar
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (04) : 638 - 638
  • [34] INTERVENTION EFFECTS ON DIET AND EXERCISE IN MINORITIES WITH T2D
    Inouye, J.
    Yomogida, J.
    Davis, J.
    Arakaki, R.
    Li, D.
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2014, 21 : S65 - S65
  • [36] Postmenopausal hormone therapy and glucose regulation in T1D and T2D
    Clauss, Maria
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 20 - 20
  • [37] Influence of Dietary Salt Intake on T2D Treatment
    Li, Li
    Mi, Yuwei
    Xu, Miao
    Ruan, Liemin
    Sun, Jie
    Song, Qifa
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] T2D: Genetic risk to be considered in Nutrition Strategy
    Metzger, Leandra
    [J]. AKTUELLE ERNAHRUNGSMEDIZIN, 2022, 47 (01): : 10 - 10
  • [39] Partial Reversal of T2D Through Dietary Manipulation
    Shankhdhar, L. K.
    Shankhdhar, Kshitij
    Shankhdhar, Smita
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S20 - S20
  • [40] Mitochondria-Associated Membranes Are Not Altered in T2D
    Hart, Samantha
    [J]. OBESITY, 2023, 31 : 219 - 220